secwatch.observer — SEC 8-K summary
======================================

Issuer:     PFIZER INC (PFE)
CIK:        0000078003
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0000078003-26-000005
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pfizer reports FY2025 revenue $62.6B, adj. EPS $3.22; reaffirms FY2026 guidance
-------------------------------------------------------------------------------

- Full-year 2025 revenue $62.6B (-2% operational); non-COVID portfolio +6% operational.
- FY2025 reported diluted EPS $1.36; adjusted diluted EPS $3.22 (+4% YoY).
- Q4 2025 revenue $17.6B (-1%); Q4 reported LPS ($0.29); adj. diluted EPS $0.66.
- Completed Metsera acquisition (~$7B); ViiV stake sale for $1.875B; reaffirms FY2026 revenue guidance $59.5-62.5B, adj. EPS $2.80-3.00.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/0000078003-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/pfe-20260203.htm
  HTML page:      https://secwatch.observer/filing/0000078003-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer